Integrative Proteomic Profiling Reveals PRC2-Dependent Epigenetic Crosstalk Maintains Ground-State Pluripotency.


Journal

Cell stem cell
ISSN: 1875-9777
Titre abrégé: Cell Stem Cell
Pays: United States
ID NLM: 101311472

Informations de publication

Date de publication:
03 01 2019
Historique:
received: 04 08 2017
revised: 06 04 2018
accepted: 12 10 2018
pubmed: 26 11 2018
medline: 4 3 2020
entrez: 26 11 2018
Statut: ppublish

Résumé

The pluripotent ground state is defined as a basal state free of epigenetic restrictions, which influence lineage specification. While naive embryonic stem cells (ESCs) can be maintained in a hypomethylated state with open chromatin when grown using two small-molecule inhibitors (2i)/leukemia inhibitory factor (LIF), in contrast to serum/LIF-grown ESCs that resemble early post-implantation embryos, broader features of the ground-state pluripotent epigenome are not well understood. We identified epigenetic features of mouse ESCs cultured using 2i/LIF or serum/LIF by proteomic profiling of chromatin-associated complexes and histone modifications. Polycomb-repressive complex 2 (PRC2) and its product H3K27me3 are highly abundant in 2i/LIF ESCs, and H3K27me3 is distributed genome-wide in a CpG-dependent fashion. Consistently, PRC2-deficient ESCs showed increased DNA methylation at sites normally occupied by H3K27me3 and increased H4 acetylation. Inhibiting DNA methylation in PRC2-deficient ESCs did not affect their viability or transcriptome. Our findings suggest a unique H3K27me3 configuration protects naive ESCs from lineage priming, and they reveal widespread epigenetic crosstalk in ground-state pluripotency.

Identifiants

pubmed: 30472157
pii: S1934-5909(18)30498-3
doi: 10.1016/j.stem.2018.10.017
pii:
doi:

Substances chimiques

Chromatin 0
Histones 0
Proteome 0
Polycomb Repressive Complex 2 EC 2.1.1.43

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

123-137.e8

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

Guido van Mierlo (G)

Department of Molecular Biology, Faculty of Science, Radboud University, Radboud Institute for Molecular Life Sciences (RIMLS), 6525GA Nijmegen, the Netherlands.

René A M Dirks (RAM)

Department of Molecular Biology, Faculty of Science, Radboud University, Radboud Institute for Molecular Life Sciences (RIMLS), 6525GA Nijmegen, the Netherlands.

Laura De Clerck (L)

Laboratory of Pharmaceutical Biotechnology, Ghent University, 9000 Ghent, Belgium.

Arie B Brinkman (AB)

Department of Molecular Biology, Faculty of Science, Radboud University, Radboud Institute for Molecular Life Sciences (RIMLS), 6525GA Nijmegen, the Netherlands.

Michelle Huth (M)

Department of Molecular Biology, Faculty of Science, Radboud University, Radboud Institute for Molecular Life Sciences (RIMLS), 6525GA Nijmegen, the Netherlands.

Susan L Kloet (SL)

Department of Molecular Biology, Faculty of Science, Radboud University, Radboud Institute for Molecular Life Sciences (RIMLS), 6525GA Nijmegen, the Netherlands.

Nehmé Saksouk (N)

Institute of Human Genetics, CNRS-Université de Montpellier UMR 9002, 34000 Montpellier, France.

Leonie I Kroeze (LI)

Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Nijmegen Medical Centre (RadboudUMC), 6525GA Nijmegen, the Netherlands.

Sander Willems (S)

Laboratory of Pharmaceutical Biotechnology, Ghent University, 9000 Ghent, Belgium.

Matthias Farlik (M)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.

Christoph Bock (C)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.

Joop H Jansen (JH)

Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Nijmegen Medical Centre (RadboudUMC), 6525GA Nijmegen, the Netherlands.

Dieter Deforce (D)

Laboratory of Pharmaceutical Biotechnology, Ghent University, 9000 Ghent, Belgium.

Michiel Vermeulen (M)

Department of Molecular Biology, Faculty of Science, Radboud University, Radboud Institute for Molecular Life Sciences (RIMLS), 6525GA Nijmegen, the Netherlands; Department of Molecular Biology, Radboud Institute for Molecular Life Sciences (RIMLS), Oncode Institute, Radboud University, Nijmegen, the Netherlands.

Jérôme Déjardin (J)

Institute of Human Genetics, CNRS-Université de Montpellier UMR 9002, 34000 Montpellier, France.

Maarten Dhaenens (M)

Laboratory of Pharmaceutical Biotechnology, Ghent University, 9000 Ghent, Belgium.

Hendrik Marks (H)

Department of Molecular Biology, Faculty of Science, Radboud University, Radboud Institute for Molecular Life Sciences (RIMLS), 6525GA Nijmegen, the Netherlands. Electronic address: h.marks@ncmls.ru.nl.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH